Inventaire - your friends and communities are your best library

The nature of the stable blood clot procoagulant activities

Published in: Journal of Biological Chemistry

Date of publication: February 11, 2008

Language: English

Bibliographic databases:

Cites articles 75

Date

Title

Authors

August 15, 1970

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
February 1, 1972

Preparation of suspensions of washed platelets from humans
January 1, 1976

Thrombin
November 10, 1979

The contribution of bovine Factor V and Factor Va to the activity of prothrombinase
October 1, 1980

Hageman factor fragment inhibitor in corn seeds: purification and characterization
January 1, 1981

Isolation of functional human coagulation factor V by using a hybridoma antibody
January 1, 1981

A simplified procedure for purification of human prothrombin, factor IX and factor X,A Simplified Procedure for Purification of Human Prothrombin, Factor IX and Factor X
January 1, 1981

Factor V
May 1, 1982

Progressive development of a thrombin inhibitor binding site
February 1, 1982

Inhibition of human factor Xa by various plasma protease inhibitors
May 1, 1983

The interaction of bovine factor V and factor V-derived peptides with phospholipid vesicles
August 1, 1983

Thrombin activity of fibrin thrombi and soluble plasmic derivatives
June 1, 1984

Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma
February 1, 1985

Reactive site peptide structural similarity between heparin cofactor II and antithrombin III
March 5, 1987

Activation of human prothrombin by human prothrombinase. Influence of factor Va on the reaction mechanism
January 1, 1988

Human fibrinogen
February 1, 1988

Clotting of bovine fibrinogen. Kinetic analysis of the release of fibrinopeptides by thrombin and of the calcium uptake upon clotting at high fibrinogen concentrations
December 1, 1988

An inhibitory monoclonal antibody to factor X that blocks prothrombin activation but not prothrombinase enzyme assembly
May 1, 1989

Fibrin monomer protects thrombin from inactivation by heparin-antithrombin III: implications for heparin efficacy.
April 1989

Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
May 1, 1989

Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis
August 1990

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors
October 9, 1990

Proteolytic activation of human factors IX and X by recombinant human factor VIIa: effects of calcium, phospholipids, and tissue factor
July 1, 1990

Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody
January 1, 1990

Alpha-thrombin-catalyzed hydrolysis of fibrin I. Alternative binding modes and the accessibility of the active site in fibrin I-bound alpha-thrombin
September 1, 1991

Tissue factor mRNA in THP-1 monocytic cells is regulated at both transcriptional and posttranscriptional levels in response to lipopolysaccharide
July 1, 1992

Surface-dependent hemostasis
January 1, 1992

Components and assembly of the factor X activating complex
January 1, 1993

Synthetic selective inhibitors of thrombin
August 1, 1994

Tissue factor in plasma of patients with disseminated intravascular coagulation
September 1, 1994

A model for the tissue factor pathway to thrombin. I. An empirical study
May 1, 1994

Dermatan sulfate is a more potent inhibitor of clot-bound thrombin than unfractionated and low molecular weight heparins

Article -

Welcome to inventaire

The library of your friends and communities

Learn more